[1]
|
Benjamin, E.J., Levy, D., Vaziri, S.M., D’Agostino, R.B., Belanger, A.J. and Wolf, P.A. (1994) Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study. JAMA, 271, 840-844.
https://doi.org/10.1001/jama.1994.03510350050036
|
[2]
|
黄从新, 张澍, 黄德嘉, 华伟. 心房颤动: 目前的认识和治疗的建议-2018[J]. 中国心脏起搏与心电生理杂志, 2018, 32(4): 315-368.
|
[3]
|
Santhanakrishnan, R., Wang, N., Larson, M.G., Magnani, J.W., McManus, D.D., Lubitz, S.A., et al. (2016) Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation, 133, 484-492. https://doi.org/10.1161/CIRCULATIONAHA.115.018614
|
[4]
|
Craig, T., January, L., Wann, S., Calkins, H., Cigarroa, J.E., Cleveland Jr., J.C., et al. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the heart Rhythm Society. Circulation, 130, e199-e267.
|
[5]
|
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018 [J]. 中华心血管病杂志, 2018, 46(10): 760-789.
|
[6]
|
McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Böhm, M., et al. (2021) 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal, 42, 3599-3726.
https://doi.org/10.1093/eurheartj/ehab368
|
[7]
|
Jones, D.G., Haldar, S.K., Hussain, W., Sharma, R., Francis, D.P., Rahman-Haley, S.L., et al. (2013) A Randomized Trial to Assess Catheter Ablation versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure. Journal of the American College of Cardiology, 61, 1894-1903. https://doi.org/10.1016/j.jacc.2013.01.069
|
[8]
|
Gopinathannair, R., Etheridge, S.P., Marchlinski, F.E., Spinale, F.G., Lakkireddy, D. and Olshansky, B. (2015) Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management. Journal of the American College of Cardiology, 66, 1714-1728. https://doi.org/10.1016/j.jacc.2015.08.038
|
[9]
|
Deedwania, P.C. and Lardizabal, J.A. (2010) Atrial Fibrillation in Heart Failure: A Comprehensive Review. The American Journal of Medicine, 123, 198-204. https://doi.org/10.1016/j.amjmed.2009.06.033
|
[10]
|
Healey, J.S., Israel, C.W., Connolly, S.J., Hohnloser, S.H., Nair, G.M., Divakaramenon, S., et al. (2012) Relevance of Electrical Remodeling in Human Atrial fibrillation: Results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial Mechanisms of Atrial Fibrillation Study. Circulation: Arrhythmia and Electrophysiology, 5, 626-631. https://doi.org/10.1161/CIRCEP.112.970442
|
[11]
|
Li, D., Shinagawa, K., Pang, L., Leung, T.K., Cardin, S., Wang, Z., et al. (2001) Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs with Ventricular Tachypacing-Induced Congestive Heart Failure. Circulation, 104, 2608-2514. https://doi.org/10.1161/hc4601.099402
|
[12]
|
Rienstra, M., van Gelder, I.C., van den Berg, M.P., Boomsma, F. and Van Veldhuisen, D.J. (2006) Natriuretic Peptides in Patients with Atrial Fibrillation and Advanced Chronic Heart Failure: Determinants and Prognostic Value of (NT-) ANP and (NT-Pro) BNP. Europace, 8, 482-487. https://doi.org/10.1093/europace/eul060
|
[13]
|
杨俊, 凌峰, 彭文辉, 潘浩, 徐海鹰, 王宁夫. 房颤患者心钠肽和脑钠肽水平与左室舒张功能相关性研究[J]. 中国老年学杂志, 2007, 27(22): 2229-2230.
|
[14]
|
潘文志, 巩雪, 周京敏, 舒先红, 宿燕岗, 葛均波. 心房颤动对不同心功能分级的患者血浆脑钠肽水平的影响[J]. 中华心律失常学杂志, 2009, 13(3): 213-216.
|
[15]
|
郭长磊, 李红军. 心力衰竭合并房颤患者血浆脑钠肽水平的变化及相关分析[J]. 山东医药, 2010, 50(49): 47-48.
|
[16]
|
Linssen, G.C., Rienstra, M., Jaarsma, T., Voors, A.A., van Gelder, I.C., Hillege, H.L., et al. (2011) Clinical and Prognostic Effects of Atrial Fibrillation in Heart Failure Patients with Reduced and Preserved Left Ventricular Ejection Fraction. European Journal of Heart Failure, 13, 1111-1120. https://doi.org/10.1093/eurjhf/hfr066
|
[17]
|
张清云, 周芸玲, 唐杰, 邹兰, 罗卉, 肖莲, 等. 慢性心力衰竭合并房颤患者血浆BNP水平的变化[J]. 中国循证心血管医学杂志, 2016, 8(7): 878-880.
|
[18]
|
Parekh, N. and Maisel, A.S. (2009) Utility of B-Natriuretic Peptide in the Evaluation of Left Ventricular Diastolic Function and Diastolic Heart Failure. Current Opinion in Cardiology, 24, 155-160.
https://doi.org/10.1097/HCO.0b013e328320d82a
|
[19]
|
高珍. 心力衰竭患者血浆脑钠肽的变化及意义[J]. 中华全科医学, 2013(3): 411-412.
|
[20]
|
Silver, M.A., Maisel, A.S., Yancy, C.W., McCullough, P.A., Burnett Jr., J.C., Francis, G.S., et al. (2004) BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases. Congestive Heart Failure, 10, 1-30.
https://doi.org/10.1111/j.1527-5299.2004.03271.x
|
[21]
|
Nishikimi, T., Maeda, N. and Matsuoka, H. (2006) The Role of Natriuretic Peptides in Cardioprotection. Cardiovascular Research, 69, 318-328. https://doi.org/10.1016/j.cardiores.2005.10.001
|